2019 Webinar CEU
Support: This activity received support in the form of unrestricted educational grants from Amplifon and Colgate Oral Pharmaceuticals.
March 26, 2019. 12:30-1:30pm EST, 9:30am PST
You, Optometry and Diabetes: Core Concepts, Drivers and Bridges to Interdisciplinary Care
Speaker: Michael r. dueñas, od, fnap- chief public health officer, american optometric association
Abstract: This webinar will discuss all forms of diabetic eye disease that have the potential to cause severe vision loss and blindness. These conditions include diabetic retinopathy, diabetic macular edema (DME), cataract, and glaucoma. It will help to educate the inter professional collaboration team (PPOD+A and medical diabetes care professionals), on the theory and practice of diabetes eye care delivery, to empower them to influence patient health outcomes in positive and meaningful ways. We will explore the epidemiology of diabetes, drivers to reducing diabetes complications, bridges to early T2DM prevention and detection, new research & therapies and current & proposed health policy.
Bio: Dr. Dueñas, is a graduate of the University of Florida (B.S.) and the University of Alabama, UAB Medical Center - School of Optometry (O.D.). Work experience includes; bench and translation research, private clinical and hospital-based practice, interdisciplinary teaching (Optometry/Pharmacy/Dentistry), with over a decade of service to the U.S. Centers for Disease Control and Prevention (CDC). As a health scientist and clinician, Dr. Dueñas is responsible for bringing the diabetes integrative practice model; Pharmacy, Podiatry, Optometry and Dentistry (PPOD), to the CDC. Dr. Dueñas is Immediate Past Chair of the Patient Centered Outcomes Research Institute (PCORI), Advisory Panel on Improving Healthcare Systems and has testified before the 111th US Congress on vision and eye health issues.
After completing this activity, the participant should be better able to:
1.) Describe the workings of the human eye and vision system.
2.) Stratify patient risk of vision complications and appropriately refer patients with all forms of diabetic eye disease for further evaluation and care.
3.) Explain the current diabetes clinical practice guidelines and system gaps that can be filled to better promote patient centric diabetes care.
4.) Discuss the value of team health care to the betterment of overall health of individuals with all forms of diabetes.
This activity is intended for physicians, nurses, dietitians, pharmacists, podiatrists, optometrists, dentists and audiologists engaged in the care of patients with diabetes.
RELEASE DATE: march 31, 2019
EXPIRATION DATE: DECEMBER 31, 2019
Estimated time to complete activity: 1 hour(s)
For any questions relating to the certification for this activity, please contact Postgraduate Institute for Medicine at: firstname.lastname@example.org or (303) 799-1930.
Jointly provided by Postgraduate Institute for Medicine and The Audiology Project
This activity is supported by unrestricted educational grants from Amplifon and Colgate Oral Pharma.
CONTINUING EDUCATION INFORMATION:
Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The Audiology Project. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Interprofessional Continuing Education: This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Additional CEU information can be found in the replay PDF link above.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
MICHAEL R. DUEÑAS, OD, FNAP - No financial relationships to disclose
The PIM planners and managers have nothing to disclose. The Audiology Project planners and managers have nothing to disclose.
Method of Participation and Request for Credit
There are no fees for participating and receiving CME/CE credit for this activity. During the period March 31, 2019 to December 31, 2019, participants must read the learning objectives and faculty disclosures and study the educational activity. If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com .
On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 14391 . Upon registering and successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately.
For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
Computer System Requirements
System Requirements: Web Browser: Google Chrome (most recent 2 versions) Mozilla Firefox (most recent 2 versions) Internet Explorer v11 (with Adobe Flash if running Windows 7) Apple Safari (most recent 2 versions) Microsoft Edge (most recent 2 versions) Internet Connection: Computer 1Mbps or better, Mobile device 3G or better Software: GoToWebinar Mobile App Hardware: 2GB of RAM minimum, Mobile Device: iPhone 4S or later, iPad 2 or later
Concerns or complaints about a CE Provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at www.ada.org/cerp." to the ADA credit designation statement.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or 5 suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.